Literature DB >> 2450014

Preferential reduction of insulin production in mouse pancreatic islets maintained in culture after streptozotocin exposure.

D L Eizirik1, S Sandler, N Welsh, C Hellerström.   

Abstract

The ability of the pancreatic beta-cell to repair itself after a cytotoxic injury and reassume its functional activities may be a key issue in affording protection from insulin-dependent diabetes mellitus. The molecular mechanisms behind the functional responses of the beta-cell after cytotoxic damage are still largely unknown. The present study in an attempt to elucidate this issue. Mouse pancreatic islets were isolated with collagenase and, after overnight culture, exposed for 30 min at 37 C to 2.2 mM streptozotocin (SZ) or vehicle alone (controls). The islets were subsequently cultured for 6 days in medium RPMI-1640 plus 10% calf serum. After the culture they were subjected to light microscopical examinations or different functional tests during short term incubations. The SZ-treated islets showed markedly diminished insulin release after stimulation with the beta-cell nutrients glucose and leucine plus glutamine. Compounds known to increase intracellular cAMP [theophylline and (Bu)2-cAMP] were able to partially counteract the SZ-induced reduction of insulin release. Stimulation with arginine could also slightly restore the impaired insulin release. Glucose-stimulated oxygen uptake, proinsulin biosynthesis, and insulin and insulin mRNA contents were also decreased, with values at about 50% of the controls. However, the cellular contents of DNA and RNA and total protein biosynthesis rates were essentially normal. Besides mild degranulation in some islets, the morphological appearance of the SZ-treated islets did not reveal any obvious differences compared to the control islets. The present observations suggest that after a toxic injury there remains a population of partially damaged beta-cells, which are able to maintain most of their basal metabolic functions, but fail to maintain adequate insulin biosynthesis and release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450014     DOI: 10.1210/endo-122-4-1242

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Does the mitochondrial DNA play a role in the pathogenesis of diabetes?

Authors:  K D Gerbitz
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  Prolonged exposure of pancreatic islets isolated from "pre-diabetic" non-obese diabetic mice to a high glucose concentration does not impair beta-cell function.

Authors:  D L Eizirik; E Strandell; S Sandler
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin.

Authors:  D L Eizirik; E Strandell; S Sandler
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

4.  A role for polyamines in glucose-stimulated insulin-gene expression.

Authors:  N Welsh
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

5.  Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.

Authors:  O Korsgren; L Jansson; S Sandler; A Andersson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.

Authors:  R J Konrad; I Mikolaenko; J F Tolar; K Liu; J E Kudlow
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

7.  Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.

Authors:  D L Eizirik; D G Pipeleers; Z Ling; N Welsh; C Hellerström; A Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Involvement of SIRT1 in Zn2+, Streptozotocin, Non-Obese Diabetic, and Cytokine-Mediated Toxicities of β-cells.

Authors:  Christian T Sheline
Journal:  J Diabetes Metab       Date:  2012-05-31

9.  Streptozotocin is not toxic to the human fetal B cell.

Authors:  B E Tuch; J R Turtle; C J Simeonovic
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.